Clinical Trial Update: Radiofrequency Ablation For Recurrent Parathyroid Carcinoma [NA]

View source ↗

Summary

Clinical trials.gov indicates a study evaluating radiofrequency ablation for recurrent parathyroid carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parathyroid Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Parathyroid Carcinoma | NA | Status: RECRUITING